本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Allogene Therapeutics Inc.

1.44
+0.06004.35%
盘后1.440.00000.00%18:36 EDT
成交量:358.90万
成交额:499.85万
市值:3.13亿
市盈率:-1.09
高:1.46
开:1.33
低:1.32
收:1.38
数据加载中...
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/14

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/13

重要事件披露

Form 8-K - Current report
2025/02/25

重要事件披露

Form 8-K - Current report
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/29

重要事件披露

Form 8-K - Current report
2025/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

重要事件披露

Form 8-K - Current report
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities